compound 10
oral PPARg phosphorylation inhibitor, partial agonist efficacy in diabetic mouse model from structure-based virtual screen ACS Med. Chem. Lett., March 11, 2022 AstraZeneca, Gothenburg, SE
Molecules of the Month - March 2022
Molecules of the Month
- rilzabrutinib (PRN1008)
- INE963
- ulevostinag (MK-1454)
- compound 24
- compound 10
- etavopivat
- BMS-986176/LX-9211
- branaplam
- MAK683
- HR1405-01